Compare ELUT & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELUT | MNDO |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3M | 24.8M |
| IPO Year | 2020 | 2000 |
| Metric | ELUT | MNDO |
|---|---|---|
| Price | $0.95 | $1.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 476.9K | 28.6K |
| Earning Date | 03-05-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 18.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | ★ $21,746,000.00 | $19,770,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.61 |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $0.50 | $0.98 |
| 52 Week High | $3.46 | $2.13 |
| Indicator | ELUT | MNDO |
|---|---|---|
| Relative Strength Index (RSI) | 71.32 | 52.07 |
| Support Level | $0.74 | $1.19 |
| Resistance Level | $0.91 | $1.23 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 97.43 | 50.00 |
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.